Novelion Therapeutics Inc (NVLNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1993 | 12-1992 | 12-1991 | 12-1990 | 12-1989 | |
| Sales | 0 | 0 | 0 | 0 | 292 |
| Cost of Goods | 0 | 0 | 0 | 0 | 215 |
| Gross Profit | 0 | 0 | 2 | 115 | 68 |
| Operating Expenses | 12,891 | 9,958 | 12,744 | 13,407 | 12,405 |
| Operating Income | -12,891 | -9,958 | -12,744 | -13,407 | -12,113 |
| Interest Expense | 0 | 871 | 686 | 0 | 0 |
| Other Income | 161 | 1,041 | 2,254 | 3,211 | 3,065 |
| Pre-tax Income | -12,730 | -9,788 | -11,176 | -10,196 | -9,048 |
| Net Income Continuous | -9,868 | -8,089 | -9,719 | -8,715 | -7,668 |
| Net Income | $-12,730 | $-9,788 | $-11,176 | $-10,196 | $-9,048 |
| EPS Basic Total Ops | -1.45 | -1.93 | -2.20 | -2.01 | -2.10 |
| EPS Basic Continuous Ops | -1.26 | -1.29 | -1.91 | -1.72 | -1.52 |
| EPS Diluted Total Ops | -1.45 | -1.57 | -2.20 | -2.01 | -1.81 |
| EPS Diluted Continuous Ops | -1.26 | -1.29 | -1.91 | -1.72 | -1.53 |
| EBITDA(a) | $-12,891 | $-9,958 | $-12,036 | $-12,712 | $-11,387 |